Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy

SIMPLE SUMMARY: DNA topoisomerase II (TOP2) is a drug target for many types of cancers. However, clinically used TOP2 inhibitors not only kill cancer cells, but also damage normal cells, and can even give rise to other types of cancers. To discover new TOP2 inhibitors to more effectively treat cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Matias-Barrios, Victor M., Radaeva, Mariia, Ho, Chia-Hao, Lee, Joseph, Adomat, Hans, Lallous, Nada, Cherkasov, Artem, Dong, Xuesen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345109/
https://www.ncbi.nlm.nih.gov/pubmed/34359577
http://dx.doi.org/10.3390/cancers13153675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345109/
https://www.ncbi.nlm.nih.gov/pubmed/34359577
http://dx.doi.org/10.3390/cancers13153675

Ejemplares similares